AI
Monday, January 12, 2009 3:37:23 PM
FOLD:
Did you happen to hear their JP Morgan presentation? (I was out). I just saw the PR
http://finance.yahoo.com/news/Amicus-Therapeutics-Announces-prnews-14033489.html/print
On the Fabry program I was surprised the EMEA wants the trial to be a comparator against ERT (maybe you are surprised the US is not requiring that
). They didn't say directly but it is subpart H and a surrogate end point sodo you think any chance the kidney GL-3 will be measured in urine and not biopsy?
appreciate your comments. tia
Did you happen to hear their JP Morgan presentation? (I was out). I just saw the PR
http://finance.yahoo.com/news/Amicus-Therapeutics-Announces-prnews-14033489.html/print
On the Fabry program I was surprised the EMEA wants the trial to be a comparator against ERT (maybe you are surprised the US is not requiring that
). They didn't say directly but it is subpart H and a surrogate end point sodo you think any chance the kidney GL-3 will be measured in urine and not biopsy? appreciate your comments. tia
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
